跳至主要内容
临床试验/NL-OMON38761
NL-OMON38761已完成不适用

Are the levels of Advanced Glycation Endproducts (AGE*s) associated with Paratonia in Alzheimer*s Disease (AD)? - PARAGE

Hanzehogeschool Groningen0 个研究点目标入组 144 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
144

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Community dwelling patients with Alzheimer's Disease (AD) , with an established diagnosis according to the NINCDS-ARDRA criteria visiting day-care facilities.
  • - Able to walk 10 meters unassisted (walking aid is allowed)
  • - A GDS Reisberg score of 2,3,4 or 5 (the GDS Reisberg is a 7-point scale indicating the severity of cognitive and functional decline in Alzheimer*s disease, from 1= No subjective complaints of memory deficits to 7= Basic psychomotor skills and verbal ability are lost and require assistance in toileting and feeding)
  • - Having a plain colored skin (Caucasian)(due to the limitations of the AGE-reader device)

排除标准

  • - Established diagnosis of dementia type other than AD or mixed forms like AD and vascular dementia or AD and Parkinson*s disease
  • - Using psychotropic drugs, as these drugs can possibly mimic paratonic rigidity.

研究者

发起方
Hanzehogeschool Groningen

相似试验